![](https://webarchive.library.unt.edu/eot2008/20090513103858im_/http://www.cancer.gov/images/spacer.gif) |
Middle East Cancer Consortium Expanding in Size and Influence
With the addition of Turkey earlier this year, the Middle East Cancer
Consortium (MECC) continues to grow and influence cancer prevention and care in
its member countries. In June, Turkey, with a population of about 70 million,
officially joined MECC at a signing ceremony in Ankara, Turkey. Other member
countries include Cyprus, Egypt, Israel, Jordan, and the Palestinian Authority.
Turkey's addition brings the population represented by MECC to more than 160
million.
"Even in a part of the world where strife and violence are a regular
part of life, cancer is a reality that we must do our best to address," said
National Cancer Institute (NCI) Director Dr. Andrew C. von Eschenbach. "After
more than 8 years, MECC has proven that despite political and social
differences, people can come together and do the work of trying to improve
other people's lives." Much of MECC's focus has been on establishing and
supporting population-based cancer registries in member countries. With its
entry into MECC, Turkey will establish its own registry, based in the city of
Izmir. Beginning early next year with NCI funding, Dr. John Young of Emory
University will conduct a training course for Turkish cancer registrars. To
facilitate registry training, MECC has established course material and a
standards manual, which in this case will be translated into Turkish. The
standards manual has already been translated into English and Greek; Arabic and
Hebrew versions are anticipated. Staff from NCI's Surveillance, Epidemiology,
and End Results (SEER) program also have assisted MECC registries with
training, technical support, and quality control. The first-ever comparison of
cancer incidence rates in Israel and one of its Arab neighbors, Jordan, was
published in the European Journal of Cancer Prevention in 2003. The paper had
Israeli, Jordanian, and American authors, including three from NCI. This will
likely be the first of many publications based on data from MECC-affiliated
registries, explains Dr. Joe Harford, head of NCI's OIA and the primary liaison
between MECC and NCI. Plans also are underway for an NCI monograph that will
provide a more detailed analysis and commentary on cancer incidence in the
Middle East using data derived from selected MECC-affiliated registries. MECC is
also engaged in activities beyond the registries, including educational
workshops for health care professionals from MECC member countries. Earlier
this year, for example, MECC held a workshop on palliative care, with experts
from the U.S., Europe, and the Middle East serving as faculty.
"Palliative care
has been identified by the World Health Organization as one of the highest
cancer priorities for countries with the most severely limited resources,"
explains Dr. Harford. "Throughout the developing world, cancer patients often
present with more advanced, less curable cancer, making building capacity in
palliative care and symptom management all the more pressing." MECC has also
begun to expand its influence in the region beyond cancer, holding a workshop
earlier this year on disease prevention and health promotion. More about MECC
can be found on its Web site, www.mecc.cancer.gov.
|